Rudiansyah, Mohammad and Nur'amin, Hendra Wana and Agung Nugrahaningsih, Dwi Aris and Bandiara, Ria and Roesli, Rully Marsis Amirullah (2020) COVID-19: Drug development and kidney related problems. Systematic Reviews in Pharmacy, 11 (7). 106 - 112. ISSN 09762779; 09758453
Full text not available from this repository. (Request a copy)Abstract
Coronavirus Disease-2019 (COVID-19) is an extremely contagious disease affecting almost every country in the world. This disease makes some problems in the health system, society, politics, and economy. Several reports showed that mortality in COVID-19 patients was related to abnormal kidney function. This condition should be considered to prevent death. Some investigational drugs are on the way in the preclinical and clinical trials. Some of them no have a study for safety in the kidney especially in chronic kidney disease patients including those who undergo hemodialysis. Some give a satisfying effect. Understanding COVID-19, kidney diseases, and drugs will help us to get the most potent treatment. © 2020 Elsevier B.V., All rights reserved.
| Item Type: | Article |
|---|---|
| Additional Information: | Cited by: 1 |
| Uncontrolled Keywords: | antiinfective agent; dipeptidyl carboxypeptidase inhibitor; ivermectin; Article; chronic kidney failure; coronavirus disease 2019; drug potency; Eurycoma longifolia; hemodialysis; human; kidney disease; kidney function; priority journal; Severe acute respiratory syndrome coronavirus 2 |
| Subjects: | R Medicine > R Medicine (General) R Medicine > RS Pharmacy and materia medica R Medicine > RZ Other systems of medicine |
| Divisions: | Faculty of Medicine, Public Health and Nursing > Surgical Divisions |
| Depositing User: | Sri JUNANDI |
| Date Deposited: | 07 Oct 2025 01:57 |
| Last Modified: | 07 Oct 2025 01:57 |
| URI: | https://ir.lib.ugm.ac.id/id/eprint/21814 |
Actions (login required)
- View Item